🇺🇸 FDA
Patent

US 11339150

Benzimidazole compounds as HDAC6 inhibitors

granted A61KA61K45/06

Quick answer

US patent 11339150 (Benzimidazole compounds as HDAC6 inhibitors) held by OnKure, Inc. expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OnKure, Inc.
Grant date
Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K45/06